VIPI
GSK icon

Vista Investment Partners II’s GSK GSK Stock Holding History

Vista Investment Partners II’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,855
Closed -$213K – 167
2026
Q1 		$213K Buy
+3,855
New +$209K 0.1% 141

Other funds holding GSK

MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Vista Investment Partners II's GSK Position: Q2 2026 in Review

Vista Investment Partners II sold out of GSK (GSK) in Q2 2026, closing a stake of 3,855 shares — an estimated $213K sold.

Vista Investment Partners II first reported a position in GSK in Q1 2026 and held it in 1 quarter. The position peaked at $213K in Q1 2026. 412 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Vista Investment Partners II reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Vista Investment Partners II sold 3,855 GSK shares in Q2 2026, an estimated $213K.
  • Vista Investment Partners II first reported a position in GSK in Q1 2026 and held it in 1 quarter.
  • Vista Investment Partners II's GSK position peaked at $213K in Q1 2026.
  • 412 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Vista Investment Partners II's 13F filing for Q2 2026, filed 21 Jul 2026.